Literature DB >> 24783172

Serum cystatin C as a marker of renal function in critically ill patients with normal serum creatinine.

Mohammad Mahdi Sagheb1, Soha Namazi2, Bita Geramizadeh3, Amin Karimzadeh4, Mohammad Bagher Oghazian5, Iman Karimzadeh5.   

Abstract

BACKGROUND: Serum creatinine as a classic marker of renal function has several limitations in the detection of renal dysfunction.
OBJECTIVES: This study assessed the validity of serum cystatin C as a marker of renal function in critically ill patients with normal serum creatinine. PATIENTS AND METHODS: Eighty adult patients referred to intensive care units with serum creatinine levels < 1.5 mg/dL and without hemodynamic instability were chosen and their serum creatinine and cystatin C levels were measured. A 24-hour urine sample was collected to calculate creatinine clearance (Ccr). Renal dysfunction was defined as Ccr < 80 mL/min/1.73 m(2).
RESULTS: There were significant correlations between measured Ccr and 1/serum creatinine (R = 0.51, P < 0.001) and 1/serum cystatin C (R = 0.25, P = 0.028). The difference between false negative rates of serum creatinine (93.33%) and cystatin C (80%) in the detection of renal dysfunction was significant (P = 0.032). Receiver operating characteristic curve analysis illustrated that area under the curve of serum creatinine and cystatin C for detecting renal dysfunction were 0.711 and 0.607, respectively; however, this difference was not significant (P = 0.222).
CONCLUSIONS: Our data demonstrated that serum cystatin C is not superior to serum creatinine in the early detection of renal dysfunction in critically ill patients.

Entities:  

Keywords:  Acute Kidney Injury; Creatinine; Critically Ill; Cystatin C; Patients

Year:  2014        PMID: 24783172      PMCID: PMC3997954          DOI: 10.5812/numonthly.15224

Source DB:  PubMed          Journal:  Nephrourol Mon        ISSN: 2251-7006


  43 in total

1.  Relationship between serum cystatin C and creatinine in kidney and liver transplant patients.

Authors:  Jesús Hermida; Rafael Romero; J Carlos Tutor
Journal:  Clin Chim Acta       Date:  2002-02       Impact factor: 3.786

2.  Assessment of glomerular filtration rate in renal transplant patients using serum cystatin C.

Authors:  H Xu; Y Lu; D Teng; J Wang; L Wang; Y Li
Journal:  Transplant Proc       Date:  2006-09       Impact factor: 1.066

3.  Hemodynamic instability in septic shock.

Authors:  Véronique Lapointe; Drago Jocov; André Denault
Journal:  Can J Anaesth       Date:  2009-11       Impact factor: 5.063

Review 4.  Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis.

Authors:  Zhongheng Zhang; Baolong Lu; Xiaoyan Sheng; Ni Jin
Journal:  Am J Kidney Dis       Date:  2011-05-20       Impact factor: 8.860

5.  An Official ATS/ERS/ESICM/SCCM/SRLF Statement: Prevention and Management of Acute Renal Failure in the ICU Patient: an international consensus conference in intensive care medicine.

Authors:  Laurent Brochard; Fekri Abroug; Matthew Brenner; Alain F Broccard; Robert L Danner; Miquel Ferrer; Franco Laghi; Sheldon Magder; Laurent Papazian; Paolo Pelosi; Kees H Polderman
Journal:  Am J Respir Crit Care Med       Date:  2010-05-15       Impact factor: 21.405

Review 6.  Developing a consensus classification system for acute renal failure.

Authors:  John A Kellum; Nathan Levin; Catherine Bouman; Norbert Lameire
Journal:  Curr Opin Crit Care       Date:  2002-12       Impact factor: 3.687

7.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

8.  Serum cystatin C is sensitive to small changes in thyroid function.

Authors:  Peter Wiesli; Beat Schwegler; Giatgen A Spinas; Christoph Schmid
Journal:  Clin Chim Acta       Date:  2003-12       Impact factor: 3.786

9.  Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells.

Authors:  M Bjarnadóttir; A Grubb; I Olafsson
Journal:  Scand J Clin Lab Invest       Date:  1995-11       Impact factor: 1.713

10.  Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children.

Authors:  José David Herrero-Morín; Serafín Málaga; Nuria Fernández; Corsino Rey; María Angeles Diéguez; Gonzalo Solís; Andrés Concha; Alberto Medina
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  6 in total

Review 1.  Novel monitoring of renal function and medication levels in saliva and capillary blood of patients with kidney disease.

Authors:  Manal Beshay; Connie M Rhee; Kamyar Kalantar-Zadeh
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-01-01       Impact factor: 2.894

Review 2.  [Renal replacement therapy in the intensive care unit].

Authors:  M P Woznowski; L C Rump; G Schieren
Journal:  Internist (Berl)       Date:  2014-11       Impact factor: 0.743

3.  Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters.

Authors:  Parisa Ghasemiyeh; Afsaneh Vazin; Farid Zand; Elham Haem; Iman Karimzadeh; Amir Azadi; Mansoor Masjedi; Golnar Sabetian; Reza Nikandish; Soliman Mohammadi-Samani
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

4.  Detection of cystatin C biomarker for clinical measurement of renal disease by developed ELISA diagnostic kits.

Authors:  Renren Jiang; Chao Xu; Xiaoli Zhou; Tianhao Wang; Gang Yao
Journal:  J Transl Med       Date:  2014-09-12       Impact factor: 5.531

5.  Cystatin C Falsely Underestimated GFR in a Critically Ill Patient with a New Diagnosis of AIDS.

Authors:  Caitlin S Brown; Kianoush B Kashani; Jeremy M Clain; Erin N Frazee
Journal:  Case Rep Nephrol       Date:  2016-05-17

6.  Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis.

Authors:  Mahmoud Omar; Wael Abdel-Razek; Gamal Abo-Raia; Medhat Assem; Gasser El-Azab
Journal:  Int J Hepatol       Date:  2015-10-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.